169 related articles for article (PubMed ID: 35184686)
1. Ultrasound-targeted microbubble destruction-mediated miR-144-5p overexpression enhances the anti-tumor effect of paclitaxel on thyroid carcinoma by targeting STON2.
Chen X; Zhang X; Qian Y; Xia E; Wang Y; Zhou Q
Cell Cycle; 2022 May; 21(10):1058-1076. PubMed ID: 35184686
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound microbubble-mediated miR-503-5p downregulation suppressed in vitro CRC progression via promoting SALL1 expression.
Wang Y; Li Y; Li X
Tissue Cell; 2022 Jun; 76():101811. PubMed ID: 35567907
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound-Targeted Microbubble Destruction-Mediated miR-206 Overexpression Promotes Apoptosis and Inhibits Metastasis of Hepatocellular Carcinoma Cells Via Targeting PPIB.
Wu H; Xie D; Yang Y; Yang Q; Shi X; Yang R
Technol Cancer Res Treat; 2020; 19():1533033820959355. PubMed ID: 33111654
[TBL] [Abstract][Full Text] [Related]
4. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
Wang D; Zheng Y
Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
[TBL] [Abstract][Full Text] [Related]
5. miR-199b-5p-Stonin 2 axis regulates metastases and epithelial-to-mesenchymal transition of papillary thyroid carcinoma.
Ren L; Xu Y; Qin G; Liu C; Yan Y; Zhang H
IUBMB Life; 2019 Jan; 71(1):28-40. PubMed ID: 30325582
[TBL] [Abstract][Full Text] [Related]
6. UTMD-mediated delivery of miR-21-5p inhibitor suppresses the development of lung cancer.
Zhou X; Liu H; Pang Y; Wang M; Liu S
Tissue Cell; 2022 Feb; 74():101719. PubMed ID: 34979378
[TBL] [Abstract][Full Text] [Related]
7. MiR-21-5p enhances the progression and paclitaxel resistance in drug-resistant breast cancer cell lines by targeting PDCD4.
Tao L; Wu YQ; Zhang SP
Neoplasma; 2019 Sep; 66(5):746-755. PubMed ID: 31169019
[TBL] [Abstract][Full Text] [Related]
8. Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p.
Zang H; Li Y; Zhang X; Huang G
Thorac Cancer; 2020 Jul; 11(7):1891-1903. PubMed ID: 32445273
[TBL] [Abstract][Full Text] [Related]
9. miR-671-5p repressed progression of papillary thyroid carcinoma via TRIM14.
Wang WJ; Yuan Y; Zhang D; Liu P; Liu F
Kaohsiung J Med Sci; 2021 Nov; 37(11):983-990. PubMed ID: 34292652
[TBL] [Abstract][Full Text] [Related]
10. miR-183-5p promotes proliferation, invasion, and glycolysis of thyroid carcinoma cells by targeting FOXO1.
Han C; Mo K; Jiang L; Wang K; Teng L
Mol Cell Biochem; 2022 Apr; 477(4):1195-1206. PubMed ID: 35084673
[TBL] [Abstract][Full Text] [Related]
11. MiR-138-5p improves the chemosensitivity of MDA-MB-231 breast cancer cell line to paclitaxel.
Rasoolnezhad M; Safaralizadeh R; Hosseinpour Feizi MA; Banan-Khojasteh SM; Roshani Asl E; Lotfinejad P; Baradaran B
Mol Biol Rep; 2023 Oct; 50(10):8407-8420. PubMed ID: 37620737
[TBL] [Abstract][Full Text] [Related]
12. LncRNA-HCG18 regulates the viability, apoptosis, migration, invasion and epithelial-mesenchymal transition of papillary thyroid cancer cells via regulating the miR-106a-5p/PPP2R2A axis.
Zhu Y; Zhao J; Tan L; Lin S; Long M; Peng X
Pathol Res Pract; 2021 May; 221():153395. PubMed ID: 33798913
[TBL] [Abstract][Full Text] [Related]
13. Overexpression miR-211-5p hinders the proliferation, migration, and invasion of thyroid tumor cells by downregulating SOX11.
Wang L; Shen YF; Shi ZM; Shang XJ; Jin DL; Xi F
J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28703321
[TBL] [Abstract][Full Text] [Related]
14. METTL3-mediated maturation of miR-589-5p promotes the malignant development of liver cancer.
Liu J; Jiang K
J Cell Mol Med; 2022 May; 26(9):2505-2519. PubMed ID: 35348293
[TBL] [Abstract][Full Text] [Related]
15. MiR-192-5p inhibits proliferation, migration, and invasion in papillary thyroid carcinoma cells by regulation of SH3RF3.
Fu S; Ma C; Tang X; Ma X; Jing G; Zhao N; Ran J
Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34486645
[TBL] [Abstract][Full Text] [Related]
16. Curcumol inhibits the growth of xenograft-tumors in mice and the biological activities of pancreatic cancer cells by regulating the miR-21-5p/SMAD7 axis.
Fang S; Wang L; Luo C; Yi H; Wang X; Ning B
Cell Cycle; 2022 Jun; 21(12):1249-1266. PubMed ID: 35253605
[TBL] [Abstract][Full Text] [Related]
17. MiR-135a-5p modulates biological functions of thyroid carcinoma cells via targeting VCAN 3'-UTR.
Zhao X; Sun Z; Li H; Jiang F; Zhou J; Zhang L
Cancer Biomark; 2017 Aug; 20(2):207-216. PubMed ID: 28869452
[TBL] [Abstract][Full Text] [Related]
18. miR-145-5p attenuates paclitaxel resistance and suppresses the progression in drug-resistant breast cancer cell lines.
Guan X; Guan Y
Neoplasma; 2020 Sep; 67(5):972-981. PubMed ID: 32412771
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase.
Fei X; Zhang P; Pan Y; Liu Y
Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170
[TBL] [Abstract][Full Text] [Related]
20. Exosomal circDNER enhances paclitaxel resistance and tumorigenicity of lung cancer via targeting miR-139-5p/ITGB8.
Li J; Zhu T; Weng Y; Cheng F; Sun Q; Yang K; Su Z; Ma H
Thorac Cancer; 2022 May; 13(9):1381-1390. PubMed ID: 35396925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]